Vergoeding 2019-2023 voor ATC-subgroep A10BB : Sulfonylureumderivaten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| A10BB01 Glibenclamide | 56.425 | 63.420 | 12.857 | 3.480 | 7.156 |
| A10BB03 Tolbutamide | 1.436.600 | 1.405.100 | 1.253.400 | 1.058.800 | 855.380 |
| A10BB09 Gliclazide (Diamicron ®) | 6.399.600 | 6.666.500 | 8.658.800 | 9.271.300 | 13.232.000 |
| A10BB12 Glimepiride (Amaryl ®) | 768.870 | 740.330 | 677.010 | 627.450 | 528.420 |
| Totaal | 8.661.495 | 8.875.350 | 10.602.067 | 10.961.030 | 14.622.956 |